Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A First-In-Human, Phase I/IIa Trial of the Novel T Cell Immunotherapy pTTL in Patients With Advanced Colorectal Cancer

NCT05908643 is registered in ClinicalTrials.gov with Neogap Therapeutics AB as lead sponsor.

NCT NCT05908643
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05908643 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A First-In-Human, Phase I/IIa Trial of the Novel T Cell Immunotherapy pTTL in Patients With Advanced Colorectal Cancer
Lead sponsor
Neogap Therapeutics AB
Phase
Phase 1/2
Overall status
Recruiting
Start date
March 15, 2023
Completion date
June 30, 2032
Enrollment
16 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer